Qingdao NovelBeam Technology Co. Ltd. A
Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and opt… Read more
Qingdao NovelBeam Technology Co. Ltd. A (688677) - Total Liabilities
Latest total liabilities as of June 2025: CN¥253.36 Million CNY
Based on the latest financial reports, Qingdao NovelBeam Technology Co. Ltd. A (688677) has total liabilities worth CN¥253.36 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Qingdao NovelBeam Technology Co. Ltd. A - Total Liabilities Trend (2013–2024)
This chart illustrates how Qingdao NovelBeam Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Qingdao NovelBeam Technology Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Qingdao NovelBeam Technology Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PYC Therapeutics Ltd
AU:PYC
|
Australia | AU$13.27 Million |
|
Jiangsu Feymer Technology Co Ltd
SHG:688350
|
China | CN¥1.24 Billion |
|
Ginwa Enterprise Group Inc
SHG:600080
|
China | CN¥373.61 Million |
|
Guangdong Huiyun Titanium Industry
SHE:300891
|
China | CN¥1.77 Billion |
|
Moso Power Supply Technology Co Ltd
SHE:002660
|
China | CN¥758.07 Million |
|
US Century Bank
NASDAQ:USCB
|
USA | $2.59 Billion |
|
Zhuhai Rundu Pharmaceutical Co Ltd Class A
SHE:002923
|
China | CN¥1.03 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Qingdao NovelBeam Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Qingdao NovelBeam Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Qingdao NovelBeam Technology Co. Ltd. A (2013–2024)
The table below shows the annual total liabilities of Qingdao NovelBeam Technology Co. Ltd. A from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥154.64 Million | +51.45% |
| 2023-12-31 | CN¥102.10 Million | -40.31% |
| 2022-12-31 | CN¥171.05 Million | +96.51% |
| 2021-12-31 | CN¥87.04 Million | -10.83% |
| 2020-12-31 | CN¥97.62 Million | -7.05% |
| 2019-12-31 | CN¥105.02 Million | +141.69% |
| 2018-12-31 | CN¥43.45 Million | +16.87% |
| 2017-12-31 | CN¥37.18 Million | -46.12% |
| 2016-12-31 | CN¥69.00 Million | -25.51% |
| 2015-12-31 | CN¥92.63 Million | -3.21% |
| 2014-12-31 | CN¥95.70 Million | +16.18% |
| 2013-12-31 | CN¥82.37 Million | -- |